Skip to main content

Fidelity Management & Research Company

By Mallory Hackett | 12:47 pm | January 28, 2021
This latest funding announcement comes off the heels of a massive funding year for Lyra Health.   
By Aditi Pai | 10:32 am | October 15, 2015
Mail-order personal genetics service and research company 23andMe has completed a $115 million in a round led by Fidelity Management and Research Company with participation from  Casdin Capital, WuXi Healthcare Ventures, and Xfund, as well as existing investors Illumina, New Enterprise Associates, MPM Capital, and Google Ventures.